These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 32396921

  • 1. Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation.
    Fukumoto K, Fogaça MV, Liu RJ, Duman CH, Li XY, Chaki S, Duman RS.
    Neuropsychopharmacology; 2020 Sep; 45(10):1725-1734. PubMed ID: 32396921
    [Abstract] [Full Text] [Related]

  • 2. IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine.
    Deyama S, Kondo M, Shimada S, Kaneda K.
    Transl Psychiatry; 2022 May 17; 12(1):178. PubMed ID: 35577782
    [Abstract] [Full Text] [Related]

  • 3. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine.
    Fukumoto K, Fogaça MV, Liu RJ, Duman C, Kato T, Li XY, Duman RS.
    Proc Natl Acad Sci U S A; 2019 Jan 02; 116(1):297-302. PubMed ID: 30559184
    [Abstract] [Full Text] [Related]

  • 4. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.
    Deyama S, Aoki S, Sugie R, Fukuda H, Shuto S, Minami M, Kaneda K.
    Neurotherapeutics; 2023 Mar 02; 20(2):484-501. PubMed ID: 36622634
    [Abstract] [Full Text] [Related]

  • 5. 5-HT1A receptor stimulation in the medial prefrontal cortex mediates the antidepressant effects of mGlu2/3 receptor antagonist in mice.
    Fukumoto K, Iijima M, Funakoshi T, Chaki S.
    Neuropharmacology; 2018 Jul 15; 137():96-103. PubMed ID: 29738849
    [Abstract] [Full Text] [Related]

  • 6. Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine.
    Pham TH, Defaix C, Nguyen TML, Mendez-David I, Tritschler L, David DJ, Gardier AM.
    Pharmacol Biochem Behav; 2020 May 15; 192():172913. PubMed ID: 32201299
    [Abstract] [Full Text] [Related]

  • 7. The duration of the antidepressant-like effects of a single infusion of brain-derived neurotrophic factor into the medial prefrontal cortex in mice.
    Deyama S, Kaneda K.
    Behav Brain Res; 2020 Sep 15; 394():112844. PubMed ID: 32745661
    [Abstract] [Full Text] [Related]

  • 8. The postnatal 5-HT1A receptor regulates adult anxiety and depression differently via multiple molecules.
    Ishikawa C, Shiga T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug 01; 78():66-74. PubMed ID: 28483674
    [Abstract] [Full Text] [Related]

  • 9. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H, Suzuki A, Kunugi A, Tajima Y, Yamada R, Kimura H.
    Pharmacol Biochem Behav; 2021 Dec 01; 211():173289. PubMed ID: 34655652
    [Abstract] [Full Text] [Related]

  • 10. BDNF release and signaling are required for the antidepressant actions of GLYX-13.
    Kato T, Fogaça MV, Deyama S, Li XY, Fukumoto K, Duman RS.
    Mol Psychiatry; 2018 Oct 01; 23(10):2007-2017. PubMed ID: 29203848
    [Abstract] [Full Text] [Related]

  • 11. Role of 5-HT1A Receptor Stimulation in the Medial Prefrontal Cortex in the Sustained Antidepressant Effects of Ketamine.
    Fukumoto K, Iijima M, Funakoshi T, Chaki S.
    Int J Neuropsychopharmacol; 2018 Apr 01; 21(4):371-381. PubMed ID: 29309585
    [Abstract] [Full Text] [Related]

  • 12. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
    Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ.
    Eur Psychiatry; 2014 Sep 01; 29(7):419-23. PubMed ID: 24321772
    [Abstract] [Full Text] [Related]

  • 13. Isoflurane produces antidepressant effects inducing BDNF-TrkB signaling in CUMS mice.
    Zhang SS, Tian YH, Jin SJ, Wang WC, Zhao JX, Si XM, Zhang L, Xu H, Jin JY.
    Psychopharmacology (Berl); 2019 Nov 01; 236(11):3301-3315. PubMed ID: 31197433
    [Abstract] [Full Text] [Related]

  • 14. N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects.
    Fogaça MV, Fukumoto K, Franklin T, Liu RJ, Duman CH, Vitolo OV, Duman RS.
    Neuropsychopharmacology; 2019 Dec 01; 44(13):2230-2238. PubMed ID: 31454827
    [Abstract] [Full Text] [Related]

  • 15. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
    Shen M, Lv D, Liu X, Li S, Chen Y, Zhang Y, Wang Z, Wang C.
    Brain Res Bull; 2018 Oct 01; 143():58-65. PubMed ID: 30316917
    [Abstract] [Full Text] [Related]

  • 16. BDNF release is required for the behavioral actions of ketamine.
    Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS.
    Int J Neuropsychopharmacol; 2014 Oct 31; 18(1):. PubMed ID: 25539510
    [Abstract] [Full Text] [Related]

  • 17. Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.
    Ghosal S, Bang E, Yue W, Hare BD, Lepack AE, Girgenti MJ, Duman RS.
    Biol Psychiatry; 2018 Jan 01; 83(1):29-37. PubMed ID: 28751069
    [Abstract] [Full Text] [Related]

  • 18. Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex.
    Sales AJ, Fogaça MV, Sartim AG, Pereira VS, Wegener G, Guimarães FS, Joca SRL.
    Mol Neurobiol; 2019 Feb 01; 56(2):1070-1081. PubMed ID: 29869197
    [Abstract] [Full Text] [Related]

  • 19. Neurotrophic and Antidepressant Actions of Brain-Derived Neurotrophic Factor Require Vascular Endothelial Growth Factor.
    Deyama S, Bang E, Kato T, Li XY, Duman RS.
    Biol Psychiatry; 2019 Jul 15; 86(2):143-152. PubMed ID: 30712809
    [Abstract] [Full Text] [Related]

  • 20. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
    Yang C, Kobayashi S, Nakao K, Dong C, Han M, Qu Y, Ren Q, Zhang JC, Ma M, Toki H, Yamaguchi JI, Chaki S, Shirayama Y, Nakazawa K, Manabe T, Hashimoto K.
    Biol Psychiatry; 2018 Oct 15; 84(8):591-600. PubMed ID: 29945718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.